US equities |
MU $972.06 ▲+4.66% META $613.64 ▼-1.06% TSLA $401.18 ▼-1.54% SPCX $144.77 ▼-2.56% NVDA $217.04 ▼-0.41% SNDK $1,377.84 ▲+5.59% SKHY $163.96 ▲+12.80% STX $682.58 ▲+2.21%
FinancialContent

Latest News about Jim Gilligan

Recent news which mentions Jim Gilligan

Tryp Submits IND Application To FDA For Clinical Trial Of Psilocybin-Assisted Psychotherapy In Patients With IBS
Tickers EVGN TRYPF
Tags Cannabis News Benzinga
From Benzinga
EXCLUSIVE: Reinventing Mental Health & Next-Gen Psychedelics, 'Access And Clinical Data Are Key'
Tickers ENVB PSYBF TRYPF
Tags Benzinga Psychedelics Capital Conference Benzinga Enveric Biosciences
From Benzinga
Psychedelics Companies Share Corporate Updates: Numinus, Delix, Tryp And Small Pharma
Tickers DMTTF NUMIF TRYPF
Tags Jim Gilligan IMS Investor Relations Market News
From Benzinga
Clinical Trials Of Psilocybin Treatment For Overeating Disorder Are Ready, Here's What Results Show So Far
Tickers TRYPF
Tags Psychedelics Markets TRYPF
From Benzinga